RSS-Feed abonnieren
DOI: 10.1055/s-0045-1802510
Obesity related IL-6 trans-signaling is linked to BMI in pediatric asthma and associated with premature aging of respiratory epithelial cells in mice and children
Background: Obesity early in life affects the clinical course of asthma. Maternal obesity is a risk factor for childhood obesity, but the impact on asthma phenotypes is unclear. Our previously reported findings in the All-Age Asthma Cohort (ALLIANCE) study showed a clinical association between (a) maternal BMI and asthma severity in the offspring, (b) high body-mass-index (BMI) and high bodyfat-fraction (BFF) in early life and a worse symptom control of asthma, earlier onset of symptoms and lower lung function. Additionally, (c) methylome profiling with methylome-derived epigenetic clock in nasal respiratory epithelial cells (REC) of asthmatic children showed premature epithelial cell aging in overweight asthmatics. Therefore, we now investigated obesity-related inflammation, including the pathways of adipocytokine Interleukin-6 (IL-6) in (i) the ALLIANCE cohort and (ii) a murine model of perinatal obesity with pharmacological IL-6 intervention.
Methods: (i) In 324 study participants (asthmatics and controls, mean age: 9,6 years [SD: 4.0], 123 females [38%], 201 males [62%]) we conducted a cytokine cluster analysis in CD3/CD28 stimulated whole blood of asthmatic children to test for association with clinical parameters. Furthermore, in 139 patients and controls we investigated IL-6 related analytes for possible correlation with BMI and GINA symptom control in the asthmatics. (ii) In a murine perinatal obesity model, we analyzed aging-associated processes (e.g., DNA damage) in bronchial epithelial cells (BEC) via immunofluorescent staining with yH2AX after postnatal pharmacological inhibition of IL-6 cis- and trans- signaling using mIL-6Ab or sgp130Fc, respectively.
Results: On a molecular level, assessment of cytokine modules in CD3/CD28 stimulated whole blood of asthmatic children identified a cytokine cluster that correlated with high BMI (p<0,001) and lower lung function trajectory (p<0,01) in asthmatics. On a clinical level, lower levels of soluble gp130 (sgp130), a natural inhibitor of IL-6 trans-signaling, were associated with high BMI (p<0,001) and lower symptom control (p<0,01). (ii) In the murine model, perinatal obesity was linked to increased signs of aging (i.e. higher DNA damage response) in BECs, which was protected against when IL-6 trans-signaling was inhibited with sgp130Fc (p<0,01).
Conclusion: Our results highlight the impact of obesity-associated meta-inflammation, specifically the role of IL6 trans-signaling, on lower symptom control as an indicator of asthma severity in childhood. Obesity-driven premature aging of respiratory epithelial cells could be a pathomechanism for epithelial dysfunction and targeting IL-6 trans-signaling could be a novel therapeutic strategy for patients with obesity-related asthma.
Publikationsverlauf
Artikel online veröffentlicht:
28. Februar 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany